Top Markets
#1 Black Phoenix Black Phoenix +355.39%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.09%
#4 Akedo Akedo +46.58%
#5 Acurast Acurast +34.72%
#6 BasedHype BasedHype +25.74%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.14%
#8 Avantis Avantis +22.16%
#9 Cryptopia Cryptopia +21.54%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.89%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Vincerx Pharma, Inc. Vincerx Pharma, Inc.

Vincerx Pharma, Inc.

VINC
Pozycja w akcjach #40889
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical... Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
Cena akcji
$0.0127
Ostatnia synchronizacja: 2026-08-12
Kapitalizacja rynkowa
$66.48K
Zmiana (1 dzień)
-2.31%
Zmiana (1 rok)
-67.44%
Kraj
US
Handel Vincerx Pharma, Inc. (VINC)

Kategoria

Healthcare
Historia ceny akcji dla Vincerx Pharma, Inc. (VINC)
Najwyższa cena zamknięcia: $0.01 dnia 2026-08-01

Najniższa cena zamknięcia: $195.93 dnia 2020-05-01
Historia cen akcji firmy Vincerx Pharma, Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 86.64%
2025 -99.71%
2024 -70.59%
2023 -10.91%
2022 -91.75%
2021 -41.58%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $522.59 31.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $863.65 33.57%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE